Achieve Clinical Proof of Concept Through Precision Targeting of the Tumor Microenvironment With Improved Translation, Biomarkers and Safety Profiles

Time: 8:00 AM – 5:00 PM

Venue Details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Conference Only – Drug Developer: USD 2999.00,
Conference + Pre – Conference Workshop Day – Drug Developer: USD 4197.00,
Conference Only – Service Provider: USD 3699.00,
Conference + Pre – Conference Workshop Day – Service Provider: USD 5097.00,
Conference Only – Academic: USD 2199.00,
Conference + Pre – Conference Workshop Day – Academic: USD 2897.00

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, Mokkram Hossain, Senior Scientist, AstraZeneca, Michael Alonso, Vice President, Immunology and Pharmacology, Bolt Biotherapeutics, Ananta Paine, Biomarker Specialist, Boston University, Daniel Blumenthal, Associate Director, Carisma Therapeutics, David Reardon, Clinical Director and Professor of Medicine, Dana-Farber Cancer Institute, Kipp Weiskopf, Co-founder/Fellow, DEM Biopharma, and more